–
Sionna Therapeutics, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
Change from FY24 to FY25
millions USD
FY22:
FY23:
–
FY24:
−52.8
FY25:
−66.3
Change from FY22 to FY25
millions USD
FY22:
−29.3
FY23:
27.4
FY24:
−127
FY25:
−119
Change from FY24 to FY25
millions USD
FY22:
–
FY23:
–
FY24:
179
FY25:
206
millions USD
FY22:
–
FY23:
–
FY24:
−0.73
FY25:
20.7
(positive)
Change from FY22 to FY25
millions USD
FY22:
−37.9
FY23:
−44.8
FY24:
−52.8
FY25:
−66.7
All amounts in millions USD FY22, FY23: figures supplemented from Twelve Data because the SEC filings do not reach back this far.